ReneSola Stock Forecast, Price & News

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for ReneSola in the last year. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" ReneSola stock.
View analyst ratings for ReneSola or view top-rated stocks.

Wall Street analysts have given ReneSola a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but ReneSola wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

ReneSola saw a increase in short interest during the month of July. As of July 15th, there was short interest totaling 1,810,000 shares, an increase of 17.5% from the June 30th total of 1,540,000 shares. Based on an average daily trading volume, of 2,080,000 shares, the short-interest ratio is currently 0.9 days.
View ReneSola's Short Interest.

ReneSola is scheduled to release its next quarterly earnings announcement on Thursday, August 26th 2021.
View our earnings forecast for ReneSola.

ReneSola Ltd (NYSE:SOL) posted its earnings results on Tuesday, May, 25th. The semiconductor company reported $0.05 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.02) by $0.07. The semiconductor company had revenue of $22.78 million for the quarter, compared to analysts' expectations of $20 million. ReneSola had a net margin of 11.16% and a trailing twelve-month return on equity of 4.02%.
View ReneSola's earnings history.

ReneSola's stock was trading at $1.11 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, SOL shares have increased by 574.8% and is now trading at $7.49.
View which stocks have been most impacted by COVID-19.

Shares of ReneSola reverse split before market open on Friday, February 10th 2017. The 1-5 reverse split was announced on Monday, January 30th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, February 9th 2017. An investor that had 100 shares of ReneSola stock prior to the reverse split would have 20 shares after the split.

ReneSola updated its second quarter 2021 earnings guidance on Friday, June, 25th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $19 million-$22 million, compared to the consensus revenue estimate of $23.20 million.

4 analysts have issued 1-year price targets for ReneSola's stock. Their forecasts range from $8.20 to $15.00. On average, they anticipate ReneSola's stock price to reach $12.57 in the next year. This suggests a possible upside of 67.8% from the stock's current price.
View analysts' price targets for ReneSola or view top-rated stocks among Wall Street analysts.

34 employees have rated ReneSola CEO Xian Shou Li on Glassdoor.com. Xian Shou Li has an approval rating of 28% among ReneSola's employees. This puts Xian Shou Li in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Some companies that are related to ReneSola include Netlist (NLST), OSI Systems (OSIS), nLIGHT (LASR), Ichor (ICHR), ChipMOS TECHNOLOGIES (IMOS), SMART Global (SGH), Canaan (CAN), Magnachip Semiconductor (MX), FTC Solar (FTCI), Photronics (PLAB), Alpha and Omega Semiconductor (AOSL), SkyWater Technology (SKYT), Kopin (KOPN), Maxeon Solar Technologies (MAXN) and NeoPhotonics (NPTN).
View all of SOL's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other ReneSola investors own include Co-Diagnostics (CODX), Inovio Pharmaceuticals (INO), Nokia (NOK), FuelCell Energy (FCEL), Advanced Micro Devices (AMD), SunPower (SPWR), VBI Vaccines (VBIV), First Solar (FSLR), Onconova Therapeutics (ONTX) and OPKO Health (OPK).

ReneSola trades on the New York Stock Exchange (NYSE) under the ticker symbol "SOL."

ReneSola's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Harel Insurance Investments & Financial Services Ltd. (0.16%). Company insiders that own ReneSola stock include Barlow Todd and Shah Capital Management.
View institutional ownership trends for ReneSola.

SOL stock was sold by a variety of institutional investors in the last quarter, including Harel Insurance Investments & Financial Services Ltd..
View insider buying and selling activity for ReneSola or view top insider-selling stocks.

Shares of SOL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of SOL stock can currently be purchased for approximately $7.49.

ReneSola has a market capitalization of $522.41 million and generates $73.92 million in revenue each year. The semiconductor company earns $2.78 million in net income (profit) each year or $0.09 on an earnings per share basis.

ReneSola employs 147 workers across the globe.

The official website for ReneSola is www.renesolapower.com.

ReneSola is headquartered at 3RD FLOOR 850 CANAL ST, STAMFORD CT, 06902.

ReneSola's mailing address is 3RD FLOOR 850 CANAL ST, STAMFORD CT, 06902. The semiconductor company can be reached via phone at 347-577-9055 or via email at [email protected]